Comparison of Two Method Antimetabolites Application on Corneal Function in Trabeculectomy Surgery

Shahid Beheshti University of Medical Sciences

Status and phase: Unknown; Phase 2

Conditions: Glaucoma Patients Scheduled for Trabeculectomy

Treatments: Drug: Mitomycin_c

Study type: Interventional

Funder types: Other

Identifiers

NCT01297803

8772

Details and patient eligibility

About

Application of antimetabolite agents such as mitomycin_c has improved trabeculectomy results and better control of intraocular pressure complications such as corneal endothelial cell loss. However, Mitomycin_c can be applied remain a concern before or after sclera flap dissection. Mitomycin_c application after sclera flap dissection probably increases corneal endothelial cell loss. This study compares Mitomycin_c application two methods: before and after sclera flap dissection with regard to success rate and complication. patients on base of Mitomycin_c application time (1-2-3) minutes will be match randomise in to two groups( before and after sclera flap dissection) corneal. Endothelial cell density, polymorphism, polymegathism and intraocular pressure before and one month, three months, six months after surgery will measured.

Sex: All

Ages: 15 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age Range between 18 to 80 years old
• Trabeculectomy to JOAC, POAG, CACG, PXF, pigment dispersion syndrome.

Exclusion criteria

• Secondary glaucoma (active uveitis, NVG, specific syndromes such as axenfeld rieger, Iridocorneal Endothelial syndrome, aniridia, peters, etc).

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

0 participants in 2 patient groups

Mitomycin_c application before sclera flap dissection

Active Comparator group

Treatment:

Drug: Mitomycin_c

Mitomycin_c application after sclera flapdissection

Active Comparator group

Treatment:

Drug: Mitomycin_c